发明公开
- 专利标题: MODIFIED RELEASE FORMULATION
- 专利标题(中): 修改释放制剂
-
申请号: EP01963156.3申请日: 2001-08-30
-
公开(公告)号: EP1322293A1公开(公告)日: 2003-07-02
- 发明人: EKLUND, Marianne , LOFROTH, Jan-Erik , SKANTZE, Urban
- 申请人: AstraZeneca AB
- 申请人地址: 151 85 Södertälje SE
- 专利权人: AstraZeneca AB
- 当前专利权人: AstraZeneca AB
- 当前专利权人地址: 151 85 Södertälje SE
- 代理机构: Nelson, Michael Andrew
- 优先权: SE0003125 20000905
- 国际公布: WO02019990 20020314
- 主分类号: A61K9/20
- IPC分类号: A61K9/20
摘要:
A pharmaceutical modified release formulation comprising a pharmacologically active substance and a modified water-soluble polysaccharide, which modified water-soluble polysaccharide is obtainable by: a) forming a precipitate of a water-soluble polysaccharide by contacting a solution of the water-soluble polysaccharide with a solvent in which the polysaccharide is poorly soluble or insoluble; or b) milling a water-soluble polysaccharide. The modified water-soluble polysaccharides provide modified release formulations with high tablet hardness. Also claimed are a process for preparing the modified release formulation, and the use of the modified water-soluble polysaccharides as an excipient in a pharmaceutical formulation.
公开/授权文献
- EP1322293B1 MODIFIED RELEASE FORMULATION 公开/授权日:2006-09-27
信息查询